Sara S. Nogueira (2016 – 2023)"Next generation Lipid Nanoparticles for mRNA delivery" |
Lukas Uebbing (2017-2022)"Structural and Functional Characterization of Lipid-based mRNA Delivery Systems" |
Moritz Rosch (2018-2022)"A novel effervescent hydrogen-generating tablet – formulation, optimization and in-depth characterization" |
Mauricio Garcia (2018-2022)"Biopharmaceutic Prediction of Oral Absorption from Immediate Release Dosage Forms" |
Johannes Blechar (2017-2022)"Biopredictive disintegration and dissolution of solid oral dosage forms" |
Adrian Strobel (2017-2021)"Solubilization Strength Characterization of Parenteral Solutions Containing Polysorbate 80 in Support of Extractable & Leachable Studies" |
Michael Hofmann (2016-2021)"Toward biopredictive dissolution testing of BCS class II acids: insights into in vivo and in vitro dissolution of poorly soluble ionizable actives" |
Mark Denny (2014-2020)"Pharmaceutical characterization of imiquimod formulations for dermal immunization" |
Maoqi Fu (2016-2020)"Enteric coated HPMC capsules: Comparison of enteric coatings and investigation of relationship between disintegration and dissolution times" |
Philipp Gattig (2017-2020)"Entwicklung eines Computer-gestützten Ansatzes zur Verknüpfung von Qualitätsattributen und Prozessparametern unter Verwendung von maschinellem Lernen" |
Christian Siewert (2015-2019)"Pharmaceutical development of polyplex-based mRNA delivery systems" |
Antje Ziller (2015-2019)"Structural and functional characterization of lipoplexes for tumor vaccination" |
Anke Heinrich (2015-2019)"Interplay between autoinjector device and viscous protein formulations for subcutaneous administration" |
Julia Schnorr (2014-2018)"Charakterisierung parenteraler Eisenkomplexe: Untersuchungen zu Physikochemie, in-vitro-Verhalten und Austauschbarkeit von Eisen „non-biological complex drugs“" |
Kamran Zaheer (2014-2018)"Evaluation of formulation and processing factors on the disintegration and dissolution of immediate release tablets in fed state: Formulation strategy towards minimizing viscosity-mediated negative food effect" |
Deborah Bickmann (2005-2017)"Modelling the performance of inhalation devices in adults and children: Development and evaluation of new in vitro and in silico models" |
Kristin Forner (2013-2017)"Formulation effects on oral drug absorption: Key parameters for the biopredictivity of dissolution/permeation experiments" |
Jayachandar Gajendran (2007-2017)"Performance testing of medicated chewing gums with the goal of establishing in vitro in vivo correlations" |
Anna Maria Ciciliani (2012-2017)"Pharmazeutische Aerosole für pädiatrische und geriatrische Patienten" |
Maartje Elizabeth Kubbinga (2009-2016)"BCS-based biowaivers:risks and opportunities" |
Jozef Al-Gousous (2013-2016)"Tackling the obstacles to developing enteric-coated dosage forms with quick post-gastric emptying disintegration" |
Matthias Manne Knopp (2012-2016)"Development of predictive tools for amorphous solid dosage forms" |
Julian Schichtel (2011-2016)"Determination of the dissolution behavior of celecoxib-Eudragit E 100-nanoparticles using cross-flow filtration" |
Daniel Frache (2009-2016)"Untersuchung von Einflussparametern auf die Spray-Performance des Respimat Soft Mist Inhalers" |
Sebastian Trebbien (2011-2016)"Entwicklung eines Simulationsmodells für das Life-Cycle-Management von Arzneimitteln" |
Pooneh Khoshakhlagh (2012-2015)"FaSSIF-C, a cholesterol containing biorelevant intestinal model medium for development and test of oral drug formulations" |
Raphael Johnson (2012-2015)"Amphotericin B Nano-formulations: Development, characterization and suitability for oral administration" |
Mai Anh Nguyen (2011-2015)"The influence of quercetin and naringin on drug transport and metabolism in humans – Implications for the evaluation of neutraceutical-drug interactions" |
Sarah Kindgen (2012-2015)"Hydrodynamics and solid dosage form disintegration/dissolution: Immediate release tablets and novel in situ polyelectrolyte gastroretentive drug delivery systems" |
Kathrin Gerlich (2012-2015)"Entwicklung einer neuen Wassergehaltsbestimmungs-methode für feste Arzneiformen mittels elektrischer Leitfähigkeit" |
Emre Türelli (2008-2015)"Nanoparticle preparation process using novel microjet reactor technology for enhancing dissolution rates of poorly water soluble drugs" |
Karsten Gogoll (2010-2014)"JOGU: Imiquimod based transcutaneous immunization – insights and novel concepts" |
Sören Fütterer (2009-2014)"JOGU: Nanoparticular iron complex drugs for parenteral administration – Physicochemical characterization, biological distribution and pharmacological safety" |
Simon Geißler (2008-2014)"JOGU: Small scale processing of nanoscopic formulations for preclinical development of poorly soluble compounds" |
Tanja Peters (2007-2013)"JOGU: Development and in vitro testing of liposomal gadolinium formulations for neutron capture therapy of glioblastoma multiforme" |
Eva Hühn (2008-2013)"JOGU: Rational design of sustained release liposomal mRNA formulations for parenteral administration and image-guided assessment of in vivo performance" |
Robert Winkler (2010-2013)"JOGU: Konzept eines aktiven Pulverinhalators" |
Asma Abdelaziz Salim Radwan (2009-2013)"JOGU: Biopharmaceutic investigation of negative food effect for BCS class III compounds in solid dosage forms" |
Zuheir Abdelrahman Elawad Osman (2009-2012)"JOGU: Investigation of different shellac grades and improvement of release from air suspension coated pellets" |
Karl Buch (2005-2011)"JOGU: Lanthanide-loaded nanoparticles as a novel radioenhancer in radiation therapy of cancer" |
Lukas Mühlfeld (2008-2011)"JOGU: Einflüsse von Folienqualität und Blister-Design auf die Funktionalität von Blisterverpackungen" |
Andrea Hartung (2008-2011)"JOGU: Prozess Analytische Technologien „PAT“ zur Optimierung von Wirbelschichtgranulationsprozessen" |
Olga Pfeifer-Lehmann (2006-2010)"JOGU: Untersuchung der Adhäsionskräfte in interaktiven Pulvermischungen zur Inhalation und deren Veränderung in Abhängigkeit von der Dichtigkeit der Verpackung" |
Markus Jahn (2004–2009)"JOGU: Struktur, Stabilität, Toxizität und zelluläre Aufnahme von Eisenoxid- und Eisenhydroxid Nanopartikeln" |
Gamal Shazly (2005-2009)"JOGU: Effect of drug physicochemical properties on the release from liposomal systems in vitro and in vivo" |
Stefan Grube (2005-2008)"JOGU: Excipient- and food-drug interactions with spezial emphasis on trospium" |
Claudius Weiler (2004-2008)"JOGU: Generierung leicht dispergierbarer Inhalationspulver mittels Sprühtrocknung" |
Natalie Devi Glube, (2001-2007)"JOGU: The potential of the human kidney cell line Caki-1, as an in vitro sceening system for drug interactions with organic cation transporters" |
N. Ceren Alemdaroglu (2004-2007)"JOGU: Impact of folate absorption and transport for nutrition and drug targeting" |
Marija Tubic-Grozdanis (2003-2007)"JOGU: Biopharmaceutical characterization of modified-release dosage forms of P-glycoprotein and CYP 3A4 substrates in silico and in humans" |
Torsten Mau (1999-2006)"JOGU: Entwicklung und Charakterisierung von Gassterilisationsprozessen am Beispiel der Oberflächensterilisation mittels Wasserstoffperoxid und Ethylenoxid" |
Isabell Andrea Schöttle (2001-2005)"JOGU: Sprühgetrocknete Polylaktid, Poly(Laktid-co-glycolid) Mikropartikel zur Steuerung der Freisetzung aus pulmonalen Arzneiformen" |
Marcus Hans Knöll (2002-2006)"JOGU: Enteric coated mucoadhesive micropellets in rotary agglomeration process for wet spheronization" |
Bianca Beilmann (2003-2006)"JOGU:Evaluierung und Quantifizierung von Einflussfaktoren auf die aerodynamischen Eigenschaften inhalativer Pulvermischungen" |
Monika Ofer (Mainz 2004)"Modulation of Membrane Transport - A Mechanism to Explain Kinetic Interactions Between Drugs and Flavonoids" |
Amal El Saeih Fadl Abou El Ela (Mainz 2003)"Implications of Physicochemical Parameters for Carrier-Mediated and Passive Membrane Transport for Psychoactive Drugs" |
Martin Becker (Mainz 2003)"Charakterisierung der Arzneistoffabsorption aus flüssigen Externa zur kutanen Anwendung am Tier" |
Katharina Brodka-Pfeiffer (Mainz 2003)"Einfluss von Mikronisierungsprozessen auf die physikochemische Stabilität von Pulvern für Inhalationszwecke. Kriterien für die Auswahl von Konditionierungsparametern." |
Daniel Wagner (Mainz 2003)"Sustained-release formulations for compounds underlying intestinal drug efflux" |
Annette Koggel (Mainz 2002)"Influence of Secretory Transporters on the Intestinal Permeability of Cationic Drugs" |